JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3201
CALL
Cognizant
CTSH
$26.9B
| $1.94M | ﹤0.01% |
27,300
-16,300
| -37% | -$1.19M |
2017 Q1
3 quarters
|
|
3202
Novanta
NOVT
$5.61B
| $1.94M | ﹤0.01% |
38,780
+10,967
| +39% | +$534K |
2016 Q2
6 quarters
|
|
3203
AppFolio
APPF
$7.23B
| $1.94M | ﹤0.01% |
46,676
+6,597
| +16% | +$296K |
2017 Q3
1 quarter
|
|
3204
Veeco
VECO
$3.66B
| $1.94M | ﹤0.01% |
130,474
+68,237
| +110% | +$1.18M |
2016 Q3
5 quarters
|
|
3205
First Trust Senior Loan Fund ETF
FTSL
$2.43B
| $1.94M | ﹤0.01% |
40,262
+3,182
| +9% | +$153K |
2015 Q2
10 quarters
|
|
|
P
3206
CALL
DELISTED
Pandora Media Inc
P
| $1.93M | ﹤0.01% |
+400,000
| New | +$2.39M |
2017 Q4
0 quarters
|
|
3207
PUT
Capri Holdings
CPRI
$1.63B
| $1.93M | ﹤0.01% |
30,600
+10,600
| +53% | +$581K |
2016 Q2
6 quarters
|
|
|
SGEN
3208
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.93M | ﹤0.01% |
+36,000
| New | +$2.1M |
2017 Q4
0 quarters
|
|
3209
Graham Corp
GHM
$1.08B
| $1.92M | ﹤0.01% |
91,925
-19,045
| -17% | -$385K |
2015 Q4
8 quarters
|
|
3210
CALL
Corpay
CPAY
$25.7B
| $1.92M | ﹤0.01% |
+10,000
| New | +$1.76M |
2017 Q4
0 quarters
|
|
3211
PUT
General Mills
GIS
$16.8B
| $1.92M | ﹤0.01% |
32,400
+25,000
| +338% | +$1.35M |
2016 Q3
5 quarters
|
|
3212
PUT
Canadian Solar
CSIQ
$781M
| $1.92M | ﹤0.01% |
113,700
-193,700
| -63% | -$3.33M |
2016 Q2
6 quarters
|
|
3213
Hackett Group
HCKT
$267M
| $1.92M | ﹤0.01% |
122,058
-16,673
| -12% | -$258K |
2015 Q4
8 quarters
|
|
3214
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$7.68B
| $1.92M | ﹤0.01% |
109,883
-2,377
| -2% | -$41.2K |
2016 Q2
6 quarters
|
|
3215
Global Indemnity Group
GBLI
$361M
| $1.91M | ﹤0.01% |
45,436
+261
| +0.6% | +$11.1K |
2013 Q2
18 quarters
|
|
|
TEF
3216
DELISTED
Telefonica
TEF
| $1.91M | ﹤0.01% |
243,592
-24,534
| -9% | -$201K |
2013 Q2
18 quarters
|
|
3217
First Trust Health Care AlphaDEX Fund
FXH
$1.13B
| $1.9M | ﹤0.01% |
27,157
-461
| -2% | -$31.5K |
2013 Q2
18 quarters
|
|
3218
OrthoPediatrics
KIDS
$562M
| $1.9M | ﹤0.01% |
+98,727
| New | +$1.89M |
2017 Q4
0 quarters
|
|
3219
Independence Realty Trust
IRT
$3.43B
| $1.89M | ﹤0.01% |
187,451
-216,432
| -54% | -$2.23M |
2016 Q1
7 quarters
|
|
|
CWEN.A
3220
PUT
DELISTED
Clearway Energy Class A
CWEN.A
| $1.89M | ﹤0.01% |
100,000
| – | – |
2017 Q3
1 quarter
|
|
|
VESH
3221
DELISTED
Virtus Enhanced Short U.S. Equity ETF
VESH
| $1.88M | ﹤0.01% |
82,200
| – | – |
2017 Q2
2 quarters
|
|
3222
Buckle
BKE
$2.22B
| $1.88M | ﹤0.01% |
79,006
+41,053
| +108% | +$809K |
2014 Q4
12 quarters
|
|
3223
Materion
MTRN
$6.17B
| $1.87M | ﹤0.01% |
38,389
+37,889
| +7,578% | +$1.8M |
2016 Q4
4 quarters
|
|
|
FARO
3224
DELISTED
Faro Technologies
FARO
| $1.86M | ﹤0.01% |
39,683
+36,983
| +1,370% | +$1.73M |
2016 Q1
7 quarters
|
|
|
BBT
3225
Beacon Financial Corp
BBT
$2.39B
| $1.86M | ﹤0.01% |
50,720
+6,314
| +14% | +$240K |
2013 Q2
18 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.